Recurrence After Tamoxifen Could Be Dictated by Gene Expression

The expression levels of two genes could indicate whether a woman with estrogen receptor-positive breast cancer is at risk for recurrence after 5 years of tamoxifen therapy and should receive subsequent therapy.
Source: Cancer Network - Category: Cancer & Oncology Source Type: news